News by Tag: Ac220
Tasocitinib: the new drug for healing cancer
March 4, 2011
AC220, PIK-93, Tivozanib, kinase inhibitor drugs, BI-2536 along with Tasocitinib are the latest inhibitors that have proved to be of great aid.
March 4, 2011
AC220, PIK-93, Tivozanib, kinase inhibitor drugs, BI-2536 along with Tasocitinib are the latest inhibitors that have proved to be of great aid.
Su-5402 A New Ray of Light in the Research for an Anti Cancer Drug
February 18, 2011
With the discovery of the AC220, it became quite possible curing acute myeloid leukemia. This disease affects a person generally at his adult age and the symptoms get on growing worse along with the increase of the age.
February 18, 2011
With the discovery of the AC220, it became quite possible curing acute myeloid leukemia. This disease affects a person generally at his adult age and the symptoms get on growing worse along with the increase of the age.
A Proper Flow of Supply of Kinase Product Enhances The Developmental Process
January 6, 2011
The drug discovery process is a complicated one and the researchers engage in the process do not have much time to concentrate into any other fields. A constant development is necessary to enhance the process.
January 6, 2011
The drug discovery process is a complicated one and the researchers engage in the process do not have much time to concentrate into any other fields. A constant development is necessary to enhance the process.